Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 19/20 | 0.49 |
| ▸ | TACR3 | P29371 | 4/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8921070 | 0.85 | TACR1 (0.62) | TACR1KCNH2SLC6A4 | |
| SCHEMBL8922013 | 0.85 | TACR1 (0.62) | TACR1KCNH2SLC6A4 | |
| SCHEMBL8921078 | 0.85 | TACR1 (0.62) | TACR1KCNH2SLC6A4 | |
| Hydrochloric Acid SCHEMBL8923349 | 0.84 | TACR1 (0.61) | TACR1KCNH2SLC6A4 | |
| Hydrochloric Acid SCHEMBL9026828 | 0.84 | TACR1 (0.61) | TACR1KCNH2SLC6A4 | |
| SCHEMBL9218678 | 0.78 | TACR1 (0.66) | TACR1TACR3 | |
| SCHEMBL9023841 | 0.78 | TACR1 (0.66) | TACR1TACR3 | |
| SCHEMBL8920970 | 0.77 | TACR1 (0.65) | TACR1TACR3SLC6A4 | |
| SCHEMBL6483165 | 0.77 | TACR1 (0.45) | TACR1SLC6A4 | |
| SCHEMBL6494192 | 0.76 | TACR1 (0.59) | TACR1TACR3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1286978-A1 | CYCLOHEXYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME LTD. (GB) | 2003-03-05 | — | — | EP | disclosed |
| WO-2001087866-A1 | CYCLOHEXYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | MERCK SHARP & DOHME LIMITED (GB) | 2001-11-22 | — | — | WO | disclosed |